Wexford Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,778
Closed -$290K 281
2023
Q3
$290K Sell
20,778
-4,388
-17% -$56.1K 0.06% 156
2023
Q2
$296K Buy
+25,166
New +$287K 0.06% 154
2023
Q1
Sell
-15,914
Closed -$198K 222
2022
Q4
$198K Buy
+15,914
New +$203K 0.04% 120
2020
Q4
Sell
-30,000
Closed -$414K 373
2020
Q3
$414K Buy
+30,000
New +$441K 0.11% 94

Other funds holding SBRA

Wexford Capital's SBRA Position: Q4 2023 in Review

Wexford Capital sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 20,778 shares — an estimated $290K sold.

Wexford Capital first reported a position in SBRA in Q3 2020 and held it in 4 quarters. The position peaked at $414K in Q3 2020. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Wexford Capital reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Wexford Capital sold 20,778 Sabra Healthcare REIT shares in Q4 2023, an estimated $290K.
  • Wexford Capital first reported a position in Sabra Healthcare REIT in Q3 2020 and held it in 4 quarters.
  • Wexford Capital's Sabra Healthcare REIT position peaked at $414K in Q3 2020.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Wexford Capital's 13F filing for Q4 2023, filed 15 Feb 2024.